Integrated Care Pathway in Oncology (PASSION)

Study Overview
=================
Brief Summary
-----------------
A centralized unit for integrated management of care pathway in Oncology has been created. This unit settles the patients' appointments (biopsy, intravenous device, chemotherapy, imaging, oncologist...). The aim of this study is to assess the delay between the first appointment with the oncologist and the beginning of the antitumoral treatment, and therefore evaluate the efficacy of the care pathway unit. The second aim is to assess the satisfaction of patients and health care teams.

Detailed Description
-----------------
PASSION is a french monocentric study. For the retrospective cohort, patient will be selected through the use of data warehouse available on the HEGP. For the prospective cohort, patient will be included according to the selection criteria. Each patient will be followed up during 6 month and a satisfaction questionnaire will be completed at 1 month and 4 month of the first administration of anti-tumor therapy. For both cohort, clinical-anatomo-biological data will be collected through the use of data warehouse available on the HEGP.

Official Title
-----------------
Integrated Management of Care Pathway in Oncology. Impact on the Delay of Therapeutic Management and the Satisfaction of Patients and Carers

Conditions
-----------------
Colon Cancer, Gastric Cancer, Pancreatic Cancer, Thoracic Neoplasms, Breast Cancer, Ovarian Cancer, Bladder Cancer, Prostate Cancer

Intervention / Treatment
-----------------
* Behavioral: Care pathway unit


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Histologically proven : colon, gastric, pancreatic, prostate, bladder, breast, thoracic, or ovarian cancer First appointment for cancer care at the Hôpital Européen Georges Pompidou Intravenous antitumoral treatment Exclusion Criteria: Medical care non covered by social welfare Radiochemotherapy Death in the 6 months following first oncological appointment or absence of medical care in the year following the first oncological appointment

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 80 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Historic cohort<br>Retrospective cohort of patients that were treated in the Hôpital Européen Georges Pompidou before the creation of the care pathway unit. | |
| Prospective cohort<br>All consecutive patients that meet the inclusion criterion and will begin a cancer care after the study start. | Behavioral: Care pathway unit<br>* Patients from the prospective cohort will have their health care scheduled by the care pathway unit.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Time between the first appointment with the oncologist and the beginning of antitumoral treatment. | Delay of health care | 6 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patients satisfaction | Satisfaction of patients with OUT-PATSAT35 questionnaire (out-patient satisfaction) : Likert type scale with 5 ordered modalities (bad to excellent), rated from 1 to 5. | 6 months | 
| Health care teams satisfaction | Satisfaction of health care teams : qualitative questionnaire with 4 ordered modalities (very satisfied to not satisfied) | 6 months | 
| Rate of emergency consultations and hospitalizations | Need for unexpected health care | 6 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
care pathway, satisfaction, oncology, treatment delay